Sam Rodriques is an entrepreneur, technologist, and inventor in the biotechnology space. He has invented a new nanofabrication method, a new approach to sensing neural activity with probes in the bloodstream, and new ways to extract spatial and temporal information from RNA sequencing.
He is the founder of the Applied Biotechnology Laboratory at the Crick Institute. Prior to founding the ABL, he was an entrepreneur in residence at Petri, a biotech accelerator in Boston, Massachusetts, and co-founded Saturn5, a company developing patient-oriented neurosurgical tools.
In the spring of 2019, he graduated with a PhD in Physics at the Massachusetts Institute of Technology, having worked between the MIT Media Lab, the MIT Department of Brain and Cognitive Sciences and the Broad Institute of Harvard and MIT. Prior to that, he graduated summa cum laude with highest honors in Physics from Haverford College, where he worked on new methods for calculating quantum entanglement in multipartite quantum systems.
He has received numerous national awards and fellowships to support his studies and research, including the Hertz Foundation Graduate Fellowship, an NSF Graduate Research Fellowship and a Churchill Scholarship. He has a broad diversity of interests, ranging from diagnostics to gene therapies and new methods for detecting and treating brain disorders.